Farxiga release date?

When was Farxiga first approved and released?

Farxiga (dapagliflozin) was first approved by the U.S. FDA in January 2014, which marked the drug’s initial U.S. launch/release period. [1]

Why do some sources show different “release” dates?

People sometimes see multiple dates for Farxiga because:
- The FDA “approval date” (regulatory authorization) can differ from the date marketing starts in the U.S.
- “Release” can also mean availability for additional indications after the first approval, not the original product launch. [1]

What is the earliest FDA approval date used for Farxiga in most references?

Most drug references use the earliest FDA approval date as the de facto “release” date for the product in the U.S., which for Farxiga is January 2014. [1]

Where can I verify the exact dates for each Farxiga approval/indication?

For quick checks of launch and later exclusivity/patent-related timelines, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/ (see Farxiga/dapagliflozin pages for date details). [2]

Sources:
[1] https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots
[2] https://www.drugpatentwatch.com/